New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Precision BioSciences, Inc.
DTIL
Shape
US Flag

NASDAQ

Unprofitable

Unprofitable

54M

Biotechnology

Next Earning date - 12 May 2025

54M

Biotechnology

Next Earning date - 12 May 2025

5.13USD

Shape0.11 ( 2.19%)
sun-fogPre-market 5.18$arrow-right-up0.05 (0.96%)
Market Closed (as of Apr 21, 20:00 EDT)
favorite-chart

Relative Strenght

39
favorite-chart

Volume Buzz

-59%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

62%

Quote Panel

Shape
Updated April 22, 2025
1W 2.40 % 1M -9.04 % 3M 2.60 % 1Y -49.85 %

Key Metrics

Shape
  • Market Cap

    53.77M


  • Shares Outstanding

    10.48M


  • Share in Float

    7.67M


  • Dividende

    0


  • Earning Date

    12 May 2025


  • Price Target

    5.13


  • Average Volume

    153300


  • Beta

    1.584


  • Range

    3.61-13.436


  • Industry

    Biotechnology


  • Website

    https://www.precisionbiosciences.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

0.78x

P/S Ratio

0.64x

P/B Ratio

0.5

Debt/Equity

10.4%

Net Margin

$1.0

EPS

How DTIL compares to sector?

P/E Ratio

Relative Strength

Shape

DTIL

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

Analyst rating

Last analyst upgrade/downgrade

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

N/A

-6.91
vs -13.81

Q2.23

arrow
arrow

N/A

-3.00
vs -13.21

Q3.23

arrow
arrow

N/A

-3.00
vs -6.61

Q4.23

arrow
arrow

N/A

-3.35
vs -7.81

Q1.24

arrow
arrow

N/A

-0.35
vs -6.91

Q2.24

arrow
arrow

+215%

3.46
vs -3.00

Q3.24

arrow
arrow

N/A

-2.83
vs -3.00

Q4.24

arrow
arrow

N/A

-3.20
vs -3.35

Q1.25

arrow
arrow

N/A

-1.96
vs -0.35

Q2.25

arrow
arrow

N/A

-1.90
vs 3.46

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.23

arrow
arrow

+165%

8.8M  vs 3.3M

Q2.23

arrow
arrow

+418%

19.8M  vs 3.8M

Q3.23

arrow
arrow

+78%

13.1M  vs 7.4M

Q4.23

arrow
arrow

-34%

7M  vs 10.6M

Q1.24

arrow
arrow

+100%

17.6M  vs 8.8M

Q2.24

arrow
arrow

+152%

49.9M  vs 19.8M

Q3.24

arrow
arrow

-96%

576K  vs 13.1M

Q4.24

arrow
arrow

-91%

638K  vs 7M

Q1.25

arrow
arrow

-77%

4.1M  vs 17.6M

Q2.25

arrow
arrow

-90%

5M  vs 49.9M

Return on EquityShape

status-upQoQ

Q1.23

arrow
arrow

-59%

-0.59
vs -0.60

Q2.23

arrow
arrow

-35%

-0.35
vs -0.59

Q3.23

arrow
arrow

-28%

-0.28
vs -0.35

Q4.23

arrow
arrow

-86%

-0.86
vs -0.28

Q1.24

arrow
arrow

+23%

0.23
vs -0.86

Q2.24

arrow
arrow

+44%

0.44
vs 0.23

Q3.24

arrow
arrow

-25%

-0.25
vs 0.44

Q4.24

arrow
arrow

-31%

-0.31
vs -0.25

Institutionnal OwnershipShape

status-upQoQ

Q1.23

arrow
arrow

85

85
vs 102

-17%

Q2.23

arrow
arrow

77

77
vs 85

-9%

Q3.23

arrow
arrow

75

75
vs 77

-3%

Q4.23

arrow
arrow

63

63
vs 75

-16%

Q1.24

arrow
arrow

41

41
vs 63

-35%

Q2.24

arrow
arrow

45

45
vs 41

10%

Q3.24

arrow
arrow

50

50
vs 45

11%

Q4.24

arrow
arrow

54

54
vs 50

8%

Earnings Growth

Latest News